Biolase, Inc. · OTC:BIOLQ
Biolase — Canaccord Genuity 2012 Forum
20 slides from Biolase's conference presentation, Dec 4, 2012
Slide 1: Fred Furry, COO & CFO, December 4, 2012
Fred Furry, COO & CFO December 4, 2012 Nasdaq: BIOL PAGE Exhibit 99.1
Slide 2: Safe Harbor Statement
PAGE Safe Harbor Statement This presentation may contain forward-looking statements that are based on our current expectations, estimates and projections about our industry as well as management’s beliefs and assumptions. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks
Slide 3: BIOLASE Company Overview
We are a biomedical company focused on developing, manufacturing, and selling dental lasers using our revolutionary, proprietary WaterLase technology. Also a marketer & distributor of: – dental imaging equipment, – intra-oral scanners, and – other products designed for dental & medical procedures. N
Slide 4: BIOLASE Product Offering: Total Technology Solution
Step Technology BIOLASE Product Offering Diagnose and establish treatment protocol 3D cone beam imaging NewTom (QR/Cefla) DaVinci Imaging (Cefla) Treatment: all tissue surgical device WaterLase WaterLase iPlus WaterLase MDX WaterLase MD Turbo Treatment: soft tissue surgical device Diode laser EPIC 1
Slide 5: WaterLase is a biological method to cut tissue
WaterLase is a biological method to cut tissue. Water molecules within tissue absorb the laser energy from the WaterLase, expand, and vaporize, which causes a biological ablation of the tissue. – There is very little trauma or bleeding, – No heat or vibration are generated, and – Causes little or no
Slide 6: How It Works: WaterLase High Speed Cutting
How It Works: WaterLase High Speed Cutting
Slide 7: WaterLase Side by Side with Drill
WaterLase Side by Side with Drill PAGE
Slide 8: WaterLase Soft Tissue Lingual Frenectomy
WaterLase Soft Tissue Lingual Frenectomy PAGE
Slide 9: WaterLase Atraumatic Pediatric Tooth Extraction
PAGE 9 WaterLase Atraumatic Pediatric Tooth Extraction The WaterLase aiming beam does not cut the tissue or generate heat. The tissue is cut biologically, with little or no pain, when the laser energizes water at the molecular level.
Slide 10: BIOLASE's Market Opportunity
PAGE 10 176,000 dentists in US & Canada. 1.2M dentists in 134 countries. – rapid growth in emerging economies e.g. China, India & Indonesia. Current market penetration . – approx. 5.0% of dental practices in US. – approx. 1.5% worldwide. Each incremental 1% market penetration equals over $600M reven
Slide 11: Dominant Market Position
80% 45% Dominant Market Position Hard-tissue Dental Laser Market Total Dental Laser Market BIOLASE Market Share
Slide 12: Diode Soft-Tissue Dental Lasers
EPIC 10 total diode solution – regulatory clearance late Q3 (EU) & early Q4 (US) 2012. – cleared for 3 unique uses: Pain Therapy. iLase – portable diode laser. – no foot pedal, power cord, or external controls. Diode Soft-Tissue Dental Lasers Soft Tissue Surgery, Whitening,
Slide 13: In-Licensed Products
TRIOS intra-oral scanner and cart – digital impression taking. – handheld scanner, operator's control cart, and software. – North American distribution agreement through Aug 2017. In-Licensed Products NewTom and Cefla 3D cone beam imaging products – medical grade imaging technology. – less cost, les
Slide 14: Extensive Patent Portfolio
Issued & Active Pending Total 291 patents issued & pending 70% are related to WaterLase technology & medical lasers Extensive Patent Portfolio U.S. International Total
Slide 15: Sales and Marketing
Returned to direct sales model in N. America in August 2010 Currently consists of 47-person team: – 37 direct outside sales – 10 inside sales representatives and lead generators – Current: Irvine, CA (USA), Floss (Germany), Madrid (Spain),Shanghai (China), and Mumbai (India) – Planned: Dubai (UAE) a
Slide 16: Gross Revenue and Influencers
Gross Revenue and Influencers Launched Cefla’s NewTom Cone Beam Imaging products Introduced iLase™ hand-held soft- tissue diode laser Introduced DaVinci Imaging™ products Launched WaterLase ® iPlus™ all-tissue laser TRIOS™ intra-oral scanner CE Mark & FDA clearance for EPIC 10 Ended exclusive distri
Slide 17: Growth Strategy
Continued adoption of core WaterLase products. Drive sales of EPIC 10 diode soft-tissue laser. Growth of Imaging Division (cone beam and cad-cam) Additional new product introductions based on our core technologies. – Two 510(k) submissions currently under FDA review. – Three additional submissions p
Slide 18: Investment Considerations
Ongoing growth in WaterLase sales. Recent & planned new product introductions. – EPIC 10 & TRIOS introduced second half of 2012. – Additional product launches based on core technologies planned. Strong IP protection with additional patents pending. Addressing $50 dental laser market opportunity. – S
Slide 19: BIOLASE Today
BIOLASE Corporate Headquarters in Irvine, California Over 180 employees worldwide Sales offices in Floss (Germany), Madrid (Spain), Shanghai (China), and Mumbai (India); expansion planned in Dubai (UAE), and Rio de Janero (Brazil) Floss also has service and manufacturing capabilities BIOLASE Europe
Slide 20: Fred Furry, COO & CFO, BIOLASE, Inc.
Fred Furry COO & CFO, BIOLASE, Inc. 949.226.8124 ffurry@biolase.net Lisa Wilson President, In-Site Communications, Inc. 212.759.3929 lwilson@insitecony.com